Terumo Ultimaster Nagomi Sirolimus Eluting Coronary Stent System - HSA Registration DE0509880
Access comprehensive regulatory information for Terumo Ultimaster Nagomi Sirolimus Eluting Coronary Stent System in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0509880 and owned by Terumo Europe N.V.. The device was registered on October 07, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Ultimaster Nagomi Sirolimus eluting coronary stent system is indicated for treatment of patients with stenotic or occlusive lesions in coronary arteries, including but not limited to patients with chronic coronary syndrome, acute coronary syndrome (STEMI, NSTEMI and unstable angina), diabetes mellitus, multivessel disease, bifurcation lesions, patients older than 65 years, male and female patients, patients with totally occluded lesions, long lesions, lesions residing in small coronary vessels, restenotic lesions including in-stent restenosis, ostial lesions, lesions in left main coronary artery and arterial or venous bypass graft. The Ultimaster Nagomi stent system is suitable for both femoral and radial approach.

